Skip to main content

Aneurysm clinical trials at UCSD

4 in progress, 1 open to eligible people

Showing trials for
  • NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

    open to eligible people ages 18 years and up

    Prospective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic aortic lesions involving the aortic arch with a proximal landing zone, native or previously implanted surgical graft, in the ascending aorta and with a brachiocephalic trunk native landing zone.

    La Jolla, California and other locations

  • Chimney EndoVascular Aneurysm Sealing Of New Expanded Indication

    Sorry, in progress, not accepting new patients

    Prospective, multi-center, non-randomized study with consecutive, eligible subject enrollment at each site, for the evaluation of the ChEVAS System for Endovascular Repair of Complex Abdominal Aortic Aneurysms.

    La Jolla, California and other locations

  • Physician Modified Endograft For Complex Aortic Aneurysm Repair

    Sorry, not yet accepting patients

    The physician modified endograft is intended for treating complex, pararenal, juxtarenal and thoracoabdominal aortic aneurysms requiring coverage of renal arteries, the superior mesenteric artery or the celiac trunk in high-risk patients who do not have an option for endovascular repair with an FDA approved endograft and have an appropriate anatomy. There will be one investigational site with a total of 40 subjects to be enrolled. Time to complete enrollment will be 24 months and the subject follow-up time will be five years from last subject enrollment. The primary safety endpoint is freedom from major adverse events (MAE) at 30 days or during hospitalization if this exceeds 30 days. The primary effectiveness endpoint is the proportion of study subjects with treatment success at one year. The subjects will be followed at one month, six months, one year, and yearly thereafter for a total period of five years. Subjects will be followed up clinically for life. Clinical exam follow up may be phone or video visit with CT scan evaluation and duplex ultrasound as needed. The proportion of treatment group subjects that achieve and maintain treatment success annually to five years will be investigated.

  • Post-Approval Study of the TREO Abdominal Stent-Graft System

    Sorry, not currently recruiting here

    The purpose of this study is to determine the long-term performance of the TREO Abdominal Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms.

    La Jolla, California and other locations

Our lead scientists for Aneurysm research studies include .

Last updated: